Skip to main content
Top
Published in: Tumor Biology 12/2014

01-12-2014 | Research Article

Licochalcone A inhibits the migration and invasion of human lung cancer cells via inactivation of the Akt signaling pathway with downregulation of MMP-1/-3 expression

Authors: Hung-Che Huang, Lo-Lin Tsai, Jen-Pi Tsai, Shu-Ching Hsieh, Shun-Fa Yang, Jung-Tsung Hsueh, Yi-Hsien Hsieh

Published in: Tumor Biology | Issue 12/2014

Login to get access

Abstract

Licochalcone A (LicA), a major phenolic constituent of Glycyrrhiza inflata, has been reported to exhibit anti-tumor, anti-inflammatory, and anti-metastatic properties in various cancer cells and animal models. The aim of this study was to determine the anti-tumor effects of LicA on lung cancer cells. The results indicated that LicA exhibited effective inhibition of cell migration and invasion of A549 and H460 cells under non-cytotoxic concentrations. Furthermore, LicA was also found to significantly inhibit the proteins and messenger RNA (mRNA) expression of MMP-1 and MMP-3 in A549 cells. Moreover, treatment of A549 cells with LicA-inhibited activation of the phosphorylation of Akt and inhibition of Akt by LY294002 (PI3K inhibitor) or transfection with the constitutive active-Akt (CA-Akt) expression vector significantly abolished the LicA-inhibited migration and invasion through activation of the Akt pathway. Further mechanistic studies revealed that LicA inhibits Akt signaling pathways and downstream transcription factors Sp1 expression. These findings imply a critical role for Akt inhibition in the LicA-inhibited migration and invasion of lung cancer cells. Thus, LicA might be used as an anti-invasive agent in the treatment of lung cancer.
Literature
1.
go back to reference Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10–30.PubMed Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10–30.PubMed
2.
go back to reference Song PM, Zhang Y, He YF, Bao HM, Luo JH, et al. Bioinformatics analysis of metastasis-related proteins in hepatocellular carcinoma. World J Gastroenterol. 2008;14:5816–22.PubMedPubMedCentral Song PM, Zhang Y, He YF, Bao HM, Luo JH, et al. Bioinformatics analysis of metastasis-related proteins in hepatocellular carcinoma. World J Gastroenterol. 2008;14:5816–22.PubMedPubMedCentral
3.
go back to reference Tan W, Lu J, Huang M, Li Y, Chen M, et al. Anti-cancer natural products isolated from Chinese medicinal herbs. Chin Med. 2011;6:27.PubMedPubMedCentral Tan W, Lu J, Huang M, Li Y, Chen M, et al. Anti-cancer natural products isolated from Chinese medicinal herbs. Chin Med. 2011;6:27.PubMedPubMedCentral
4.
go back to reference Meiyanto E, Hermawan A, Anindyajati. Natural products for cancer-targeted therapy: citrus flavonoids as potent chemopreventive agents. Asian Pac J Cancer Prev. 2012;13:427–36.PubMed Meiyanto E, Hermawan A, Anindyajati. Natural products for cancer-targeted therapy: citrus flavonoids as potent chemopreventive agents. Asian Pac J Cancer Prev. 2012;13:427–36.PubMed
5.
go back to reference Tryggvason K, Hoyhtya M, Pyke C. Type IV collagenases in invasive tumors. Breast Cancer Res Treat. 1993;24:209–18.PubMed Tryggvason K, Hoyhtya M, Pyke C. Type IV collagenases in invasive tumors. Breast Cancer Res Treat. 1993;24:209–18.PubMed
6.
go back to reference Huntington JT, Shields JM, Der CJ, Wyatt CA, Benbow U, et al. Overexpression of collagenase 1 (MMP-1) is mediated by the ERK pathway in invasive melanoma cells: role of BRAF mutation and fibroblast growth factor signaling. J Biol Chem. 2004;279:33168–76.PubMed Huntington JT, Shields JM, Der CJ, Wyatt CA, Benbow U, et al. Overexpression of collagenase 1 (MMP-1) is mediated by the ERK pathway in invasive melanoma cells: role of BRAF mutation and fibroblast growth factor signaling. J Biol Chem. 2004;279:33168–76.PubMed
7.
go back to reference Hirata H, Naito K, Yoshihiro S, Matsuyama H, Suehiro Y, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter is associated with conventional renal cell carcinoma. Int J Cancer. 2003;106:372–4.PubMed Hirata H, Naito K, Yoshihiro S, Matsuyama H, Suehiro Y, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter is associated with conventional renal cell carcinoma. Int J Cancer. 2003;106:372–4.PubMed
8.
go back to reference Kemik O, Kemik AS, Sumer A, Dulger AC, Adas M, et al. Levels of matrix metalloproteinase-1 and tissue inhibitors of metalloproteinase-1 in gastric cancer. World J Gastroenterol. 2011;17:2109–12.PubMedPubMedCentral Kemik O, Kemik AS, Sumer A, Dulger AC, Adas M, et al. Levels of matrix metalloproteinase-1 and tissue inhibitors of metalloproteinase-1 in gastric cancer. World J Gastroenterol. 2011;17:2109–12.PubMedPubMedCentral
9.
go back to reference Liu H, Kato Y, Erzinger SA, Kiriakova GM, Qian Y, et al. The role of MMP-1 in breast cancer growth and metastasis to the brain in a xenograft model. BMC Cancer. 2012;12:583.PubMedPubMedCentral Liu H, Kato Y, Erzinger SA, Kiriakova GM, Qian Y, et al. The role of MMP-1 in breast cancer growth and metastasis to the brain in a xenograft model. BMC Cancer. 2012;12:583.PubMedPubMedCentral
10.
go back to reference Behrens P, Rothe M, Florin A, Wellmann A, Wernert N. Invasive properties of serous human epithelial ovarian tumors are related to Ets-1, MMP-1 and MMP-9 expression. Int J Mol Med. 2001;8:149–54.PubMed Behrens P, Rothe M, Florin A, Wellmann A, Wernert N. Invasive properties of serous human epithelial ovarian tumors are related to Ets-1, MMP-1 and MMP-9 expression. Int J Mol Med. 2001;8:149–54.PubMed
11.
go back to reference Fang S, Jin X, Wang R, Li Y, Guo W, et al. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. Carcinogenesis. 2005;26:481–6.PubMed Fang S, Jin X, Wang R, Li Y, Guo W, et al. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. Carcinogenesis. 2005;26:481–6.PubMed
12.
go back to reference Petrella BL, Armstrong DA, Vincenti MP. CCAA T-enhancer-binding protein beta activation of MMP-1 gene expression in SW1353 cells: independent roles of extracellular signal-regulated and p90/ribosomal S6 kinases. J Cell Physiol. 2011;226:3349–54. Petrella BL, Armstrong DA, Vincenti MP. CCAA T-enhancer-binding protein beta activation of MMP-1 gene expression in SW1353 cells: independent roles of extracellular signal-regulated and p90/ribosomal S6 kinases. J Cell Physiol. 2011;226:3349–54.
13.
go back to reference Brinckerhoff CE, Rutter JL, Benbow U. Interstitial collagenases as markers of tumor progression. Clin Cancer Res. 2000;6:4823–30.PubMed Brinckerhoff CE, Rutter JL, Benbow U. Interstitial collagenases as markers of tumor progression. Clin Cancer Res. 2000;6:4823–30.PubMed
14.
go back to reference Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, et al. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell. 1999;98:137–46.PubMedPubMedCentral Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, et al. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell. 1999;98:137–46.PubMedPubMedCentral
15.
go back to reference Husmann K, Arlt MJ, Muff R, Langsam B, Bertz J, et al. Matrix metalloproteinase 1 promotes tumor formation and lung metastasis in an intratibial injection osteosarcoma mouse model. Biochim Biophys Acta. 1832;2013:347–54. Husmann K, Arlt MJ, Muff R, Langsam B, Bertz J, et al. Matrix metalloproteinase 1 promotes tumor formation and lung metastasis in an intratibial injection osteosarcoma mouse model. Biochim Biophys Acta. 1832;2013:347–54.
16.
go back to reference Gonzalez-Arriaga P, Pascual T, Garcia-Alvarez A, Fernandez-Somoano A, Lopez-Cima MF, et al. Genetic polymorphisms in MMP 2, 9 and 3 genes modify lung cancer risk and survival. BMC Cancer. 2012;12:121.PubMedPubMedCentral Gonzalez-Arriaga P, Pascual T, Garcia-Alvarez A, Fernandez-Somoano A, Lopez-Cima MF, et al. Genetic polymorphisms in MMP 2, 9 and 3 genes modify lung cancer risk and survival. BMC Cancer. 2012;12:121.PubMedPubMedCentral
17.
go back to reference Isbrucker RA, Burdock GA. Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regul Toxicol Pharmacol. 2006;46:167–92.PubMed Isbrucker RA, Burdock GA. Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regul Toxicol Pharmacol. 2006;46:167–92.PubMed
18.
go back to reference Jiang J, Yuan X, Zhao H, Yan X, Sun X, et al. Licochalcone A inhibiting proliferation of bladder cancer T24 cells by inducing reactive oxygen species production. Biomed Mater Eng. 2014;24:1019–25.PubMed Jiang J, Yuan X, Zhao H, Yan X, Sun X, et al. Licochalcone A inhibiting proliferation of bladder cancer T24 cells by inducing reactive oxygen species production. Biomed Mater Eng. 2014;24:1019–25.PubMed
19.
go back to reference Chu X, Ci X, Wei M, Yang X, Cao Q, et al. Licochalcone a inhibits lipopolysaccharide-induced inflammatory response in vitro and in vivo. J Agric Food Chem. 2012;60:3947–54.PubMed Chu X, Ci X, Wei M, Yang X, Cao Q, et al. Licochalcone a inhibits lipopolysaccharide-induced inflammatory response in vitro and in vivo. J Agric Food Chem. 2012;60:3947–54.PubMed
20.
go back to reference Xiao XY, Hao M, Yang XY, Ba Q, Li M, et al. Licochalcone A inhibits growth of gastric cancer cells by arresting cell cycle progression and inducing apoptosis. Cancer Lett. 2011;302:69–75.PubMed Xiao XY, Hao M, Yang XY, Ba Q, Li M, et al. Licochalcone A inhibits growth of gastric cancer cells by arresting cell cycle progression and inducing apoptosis. Cancer Lett. 2011;302:69–75.PubMed
21.
go back to reference Kim YH, Shin EK, Kim DH, Lee HH, Park JH, et al. Antiangiogenic effect of licochalcone A. Biochem Pharmacol. 2010;80:1152–9.PubMed Kim YH, Shin EK, Kim DH, Lee HH, Park JH, et al. Antiangiogenic effect of licochalcone A. Biochem Pharmacol. 2010;80:1152–9.PubMed
22.
go back to reference Tsai JP, Hsiao PC, Yang SF, Hsieh SC, Bau DT, et al. Licochalcone A suppresses migration and invasion of human hepatocellular carcinoma cells through downregulation of MKK4/JNK via NF-kappaB mediated urokinase plasminogen activator expression. PLoS One. 2014;9:e86537.PubMedPubMedCentral Tsai JP, Hsiao PC, Yang SF, Hsieh SC, Bau DT, et al. Licochalcone A suppresses migration and invasion of human hepatocellular carcinoma cells through downregulation of MKK4/JNK via NF-kappaB mediated urokinase plasminogen activator expression. PLoS One. 2014;9:e86537.PubMedPubMedCentral
23.
go back to reference Green JA, Elkington PT, Pennington CJ, Roncaroli F, Dholakia S, et al. Mycobacterium tuberculosis upregulates microglial matrix metalloproteinase-1 and -3 expression and secretion via NF-kappaB- and activator protein-1-dependent monocyte networks. J Immunol. 2010;184:6492–503.PubMed Green JA, Elkington PT, Pennington CJ, Roncaroli F, Dholakia S, et al. Mycobacterium tuberculosis upregulates microglial matrix metalloproteinase-1 and -3 expression and secretion via NF-kappaB- and activator protein-1-dependent monocyte networks. J Immunol. 2010;184:6492–503.PubMed
24.
go back to reference Lee YR, Noh EM, Han JH, Kim JM, Hwang JK, et al. Brazilin inhibits UVB-induced MMP-1/3 expressions and secretions by suppressing the NF-kappaB pathway in human dermal fibroblasts. Eur J Pharmacol. 2012;674:80–6.PubMed Lee YR, Noh EM, Han JH, Kim JM, Hwang JK, et al. Brazilin inhibits UVB-induced MMP-1/3 expressions and secretions by suppressing the NF-kappaB pathway in human dermal fibroblasts. Eur J Pharmacol. 2012;674:80–6.PubMed
25.
go back to reference Ferrari MM, Rossi G, Biondi ML, Vigano P, Dell'utri C, et al. Type I collagen and matrix metalloproteinase 1, 3 and 9 gene polymorphisms in the predisposition to pelvic organ prolapse. Arch Gynecol Obstet. 2012;285:1581–6.PubMed Ferrari MM, Rossi G, Biondi ML, Vigano P, Dell'utri C, et al. Type I collagen and matrix metalloproteinase 1, 3 and 9 gene polymorphisms in the predisposition to pelvic organ prolapse. Arch Gynecol Obstet. 2012;285:1581–6.PubMed
26.
go back to reference Dempke WC, Suto T, Reck M. Targeted therapies for non-small cell lung cancer. Lung Cancer. 2010;67:257–74.PubMed Dempke WC, Suto T, Reck M. Targeted therapies for non-small cell lung cancer. Lung Cancer. 2010;67:257–74.PubMed
27.
go back to reference Pandey M, Mathew A, Nair MK. Global perspective of tobacco habits and lung cancer: a lesson for third world countries. Eur J Cancer Prev. 1999;8:271–9.PubMed Pandey M, Mathew A, Nair MK. Global perspective of tobacco habits and lung cancer: a lesson for third world countries. Eur J Cancer Prev. 1999;8:271–9.PubMed
28.
go back to reference Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med. 2004;350:379–92.PubMed Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med. 2004;350:379–92.PubMed
29.
go back to reference Sarkar FH, Li YW. Targeting multiple signal pathways by chemopreventive agents for cancer prevention and therapy. Acta Pharmacol Sin. 2007;28:1305–15.PubMed Sarkar FH, Li YW. Targeting multiple signal pathways by chemopreventive agents for cancer prevention and therapy. Acta Pharmacol Sin. 2007;28:1305–15.PubMed
30.
go back to reference Weng CJ, Yen GC. Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treat Rev. 2012;38:76–87.PubMed Weng CJ, Yen GC. Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treat Rev. 2012;38:76–87.PubMed
31.
go back to reference Chetty C, Rao JS, Lakka SS. Matrix metalloproteinase pharmacogenomics in non-small-cell lung carcinoma. Pharmacogenomics. 2011;12:535–46.PubMed Chetty C, Rao JS, Lakka SS. Matrix metalloproteinase pharmacogenomics in non-small-cell lung carcinoma. Pharmacogenomics. 2011;12:535–46.PubMed
32.
go back to reference Lopez-Otin C, Palavalli LH, Samuels Y. Protective roles of matrix metalloproteinases: from mouse models to human cancer. Cell Cycle. 2009;8:3657–62.PubMed Lopez-Otin C, Palavalli LH, Samuels Y. Protective roles of matrix metalloproteinases: from mouse models to human cancer. Cell Cycle. 2009;8:3657–62.PubMed
33.
go back to reference Li M, Xiao T, Zhang Y, Feng L, Lin D, et al. Prognostic significance of matrix metalloproteinase-1 levels in peripheral plasma and tumour tissues of lung cancer patients. Lung Cancer. 2010;69:341–7.PubMed Li M, Xiao T, Zhang Y, Feng L, Lin D, et al. Prognostic significance of matrix metalloproteinase-1 levels in peripheral plasma and tumour tissues of lung cancer patients. Lung Cancer. 2010;69:341–7.PubMed
34.
go back to reference Jung JS, Ahn JH, Le TK, Kim DH, Kim HS. Protopanaxatriol ginsenoside Rh1 inhibits the expression of matrix metalloproteinases and the in vitro invasion/migration of human astroglioma cells. Neurochem Int. 2013;63:80–6.PubMed Jung JS, Ahn JH, Le TK, Kim DH, Kim HS. Protopanaxatriol ginsenoside Rh1 inhibits the expression of matrix metalloproteinases and the in vitro invasion/migration of human astroglioma cells. Neurochem Int. 2013;63:80–6.PubMed
35.
go back to reference Lee EJ, Kim SY, Hyun JW, Min SW, Kim DH, et al. Glycitein inhibits glioma cell invasion through down-regulation of MMP-3 and MMP-9 gene expression. Chem Biol Interact. 2010;185:18–24.PubMed Lee EJ, Kim SY, Hyun JW, Min SW, Kim DH, et al. Glycitein inhibits glioma cell invasion through down-regulation of MMP-3 and MMP-9 gene expression. Chem Biol Interact. 2010;185:18–24.PubMed
36.
go back to reference Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, et al. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature. 1980;284:67–8.PubMed Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, et al. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature. 1980;284:67–8.PubMed
37.
go back to reference Shen H, Zeng G, Tang G, Cai X. Bi L, et al. Tumour Biol: Antimetastatic effects of licochalcone A on oral cancer via regulating metastasis-associated proteases; 2014. Shen H, Zeng G, Tang G, Cai X. Bi L, et al. Tumour Biol: Antimetastatic effects of licochalcone A on oral cancer via regulating metastasis-associated proteases; 2014.
38.
go back to reference Anand M, Van Meter TE, Fillmore HL. Epidermal growth factor induces matrix metalloproteinase-1 (MMP-1) expression and invasion in glioma cell lines via the MAPK pathway. J Neurooncol. 2011;104:679–87.PubMed Anand M, Van Meter TE, Fillmore HL. Epidermal growth factor induces matrix metalloproteinase-1 (MMP-1) expression and invasion in glioma cell lines via the MAPK pathway. J Neurooncol. 2011;104:679–87.PubMed
39.
go back to reference Petrella BL, Armstrong DA, Vincenti MP. Interleukin-1 beta and transforming growth factor-beta 3 cooperate to activate matrix metalloproteinase expression and invasiveness in A549 lung adenocarcinoma cells. Cancer Lett. 2012;325:220–6.PubMed Petrella BL, Armstrong DA, Vincenti MP. Interleukin-1 beta and transforming growth factor-beta 3 cooperate to activate matrix metalloproteinase expression and invasiveness in A549 lung adenocarcinoma cells. Cancer Lett. 2012;325:220–6.PubMed
40.
go back to reference Armstrong DA, Phelps LN, Vincenti MP. CCAAT enhancer binding protein-beta regulates matrix metalloproteinase-1 expression in interleukin-1beta-stimulated A549 lung carcinoma cells. Mol Cancer Res. 2009;7:1517–24.PubMed Armstrong DA, Phelps LN, Vincenti MP. CCAAT enhancer binding protein-beta regulates matrix metalloproteinase-1 expression in interleukin-1beta-stimulated A549 lung carcinoma cells. Mol Cancer Res. 2009;7:1517–24.PubMed
41.
go back to reference Raymond L, Eck S, Mollmark J, Hays E, Tomek I, et al. Interleukin-1 beta induction of matrix metalloproteinase-1 transcription in chondrocytes requires ERK-dependent activation of CCAAT enhancer-binding protein-beta. J Cell Physiol. 2006;207:683–8.PubMed Raymond L, Eck S, Mollmark J, Hays E, Tomek I, et al. Interleukin-1 beta induction of matrix metalloproteinase-1 transcription in chondrocytes requires ERK-dependent activation of CCAAT enhancer-binding protein-beta. J Cell Physiol. 2006;207:683–8.PubMed
42.
go back to reference Kim JK, Shin EK, Park JH, Kim YH. Antitumor and antimetastatic effects of licochalcone A in mouse models. J Mol Med (Berl). 2010;88:829–38.PubMed Kim JK, Shin EK, Park JH, Kim YH. Antitumor and antimetastatic effects of licochalcone A in mouse models. J Mol Med (Berl). 2010;88:829–38.PubMed
43.
go back to reference Deacon K, Onion D, Kumari R, Watson SA, Knox AJ. Elevated SP1 transcription factor expression and activity drives basal and hypoxia-induced vascular endothelial growth factor (VEGF) expression in non-small cell lung cancer. J Biol Chem. 2012;287:39967–81.PubMedPubMedCentral Deacon K, Onion D, Kumari R, Watson SA, Knox AJ. Elevated SP1 transcription factor expression and activity drives basal and hypoxia-induced vascular endothelial growth factor (VEGF) expression in non-small cell lung cancer. J Biol Chem. 2012;287:39967–81.PubMedPubMedCentral
44.
go back to reference Sze KM, Wong KL, Chu GK, Lee JM, Yau TO, et al. Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance. Hepatology. 2011;53:1558–69.PubMed Sze KM, Wong KL, Chu GK, Lee JM, Yau TO, et al. Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance. Hepatology. 2011;53:1558–69.PubMed
45.
go back to reference Bae IH, Park MJ, Yoon SH, Kang SW, Lee SS, et al. Bcl-w promotes gastric cancer cell invasion by inducing matrix metalloproteinase-2 expression via phosphoinositide 3-kinase, Akt, and Sp1. Cancer Res. 2006;66:4991–5.PubMed Bae IH, Park MJ, Yoon SH, Kang SW, Lee SS, et al. Bcl-w promotes gastric cancer cell invasion by inducing matrix metalloproteinase-2 expression via phosphoinositide 3-kinase, Akt, and Sp1. Cancer Res. 2006;66:4991–5.PubMed
46.
go back to reference Tang SW, Yang TC, Lin WC, Chang WH, Wang CC, et al. Nicotinamide N-methyltransferase induces cellular invasion through activating matrix metalloproteinase-2 expression in clear cell renal cell carcinoma cells. Carcinogenesis. 2011;32:138–45.PubMed Tang SW, Yang TC, Lin WC, Chang WH, Wang CC, et al. Nicotinamide N-methyltransferase induces cellular invasion through activating matrix metalloproteinase-2 expression in clear cell renal cell carcinoma cells. Carcinogenesis. 2011;32:138–45.PubMed
47.
go back to reference Roy Choudhury S, Karmakar S, Banik NL, Ray SK. Synergistic efficacy of sorafenib and genistein in growth inhibition by down regulating angiogenic and survival factors and increasing apoptosis through upregulation of p53 and p21 in malignant neuroblastoma cells having N-Myc amplification or non-amplification. Invest New Drugs. 2010;28:812–24.PubMed Roy Choudhury S, Karmakar S, Banik NL, Ray SK. Synergistic efficacy of sorafenib and genistein in growth inhibition by down regulating angiogenic and survival factors and increasing apoptosis through upregulation of p53 and p21 in malignant neuroblastoma cells having N-Myc amplification or non-amplification. Invest New Drugs. 2010;28:812–24.PubMed
48.
go back to reference Shiau RJ, Chen KY, Wen YD, Chuang CH, Yeh SL. Genistein and beta-carotene enhance the growth-inhibitory effect of trichostatin A in A549 cells. Eur J Nutr. 2010;49:19–25.PubMed Shiau RJ, Chen KY, Wen YD, Chuang CH, Yeh SL. Genistein and beta-carotene enhance the growth-inhibitory effect of trichostatin A in A549 cells. Eur J Nutr. 2010;49:19–25.PubMed
49.
go back to reference Attoub S, Hassan AH, Vanhoecke B, Iratni R, Takahashi T, et al. Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells. Eur J Pharmacol. 2011;651:18–25.PubMed Attoub S, Hassan AH, Vanhoecke B, Iratni R, Takahashi T, et al. Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells. Eur J Pharmacol. 2011;651:18–25.PubMed
Metadata
Title
Licochalcone A inhibits the migration and invasion of human lung cancer cells via inactivation of the Akt signaling pathway with downregulation of MMP-1/-3 expression
Authors
Hung-Che Huang
Lo-Lin Tsai
Jen-Pi Tsai
Shu-Ching Hsieh
Shun-Fa Yang
Jung-Tsung Hsueh
Yi-Hsien Hsieh
Publication date
01-12-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 12/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-2519-3

Other articles of this Issue 12/2014

Tumor Biology 12/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine